IRADIMED CORPORATION Statistics
Total Valuation
IRMD has a market cap or net worth of $977.02 million. The enterprise value is $924.03 million.
| Market Cap | 977.02M |
| Enterprise Value | 924.03M |
Important Dates
The next confirmed earnings date is Monday, November 3, 2025, before market open.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | Aug 18, 2025 |
Share Statistics
IRMD has 12.72 million shares outstanding. The number of shares has increased by 0.59% in one year.
| Current Share Class | 12.72M |
| Shares Outstanding | 12.72M |
| Shares Change (YoY) | +0.59% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 36.50% |
| Owned by Institutions (%) | 48.49% |
| Float | 7.20M |
Valuation Ratios
The trailing PE ratio is 47.71 and the forward PE ratio is 44.02.
| PE Ratio | 47.71 |
| Forward PE | 44.02 |
| PS Ratio | 12.56 |
| Forward PS | 11.49 |
| PB Ratio | 10.36 |
| P/TBV Ratio | 10.75 |
| P/FCF Ratio | 68.77 |
| P/OCF Ratio | 36.00 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 37.56, with an EV/FCF ratio of 65.04.
| EV / Earnings | 44.73 |
| EV / Sales | 11.90 |
| EV / EBITDA | 37.56 |
| EV / EBIT | 38.81 |
| EV / FCF | 65.04 |
Financial Position
The company has a current ratio of 8.78
| Current Ratio | 8.78 |
| Quick Ratio | 7.25 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 23.75% and return on invested capital (ROIC) is 17.07%.
| Return on Equity (ROE) | 23.75% |
| Return on Assets (ROA) | 15.15% |
| Return on Invested Capital (ROIC) | 17.07% |
| Return on Capital Employed (ROCE) | 24.39% |
| Revenue Per Employee | $485,220 |
| Profits Per Employee | $129,110 |
| Employee Count | 160 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 1.54 |
Taxes
In the past 12 months, IRMD has paid $5.38 million in taxes.
| Income Tax | 5.38M |
| Effective Tax Rate | 20.66% |
Stock Price Statistics
The stock price has increased by +46.57% in the last 52 weeks. The beta is 1.03, so IRMD's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | +46.57% |
| 50-Day Moving Average | 73.16 |
| 200-Day Moving Average | 61.24 |
| Relative Strength Index (RSI) | 57.39 |
| Average Volume (20 Days) | 63,959 |
Short Selling Information
The latest short interest is 160,353, so 1.26% of the outstanding shares have been sold short.
| Short Interest | 160,353 |
| Short Previous Month | 141,788 |
| Short % of Shares Out | 1.26% |
| Short % of Float | 2.23% |
| Short Ratio (days to cover) | 2.81 |
Income Statement
In the last 12 months, IRMD had revenue of $77.64 million and earned $20.66 million in profits. Earnings per share was $1.61.
| Revenue | 77.64M |
| Gross Profit | 59.75M |
| Operating Income | 23.81M |
| Pretax Income | 26.04M |
| Net Income | 20.66M |
| EBITDA | 24.60M |
| EBIT | 23.81M |
| Earnings Per Share (EPS) | $1.61 |
Balance Sheet
The company has $53.00 million in cash and n/a in debt, giving a net cash position of $53.00 million or $4.17 per share.
| Cash & Cash Equivalents | 53.00M |
| Total Debt | n/a |
| Net Cash | 53.00M |
| Net Cash Per Share | $4.17 |
| Equity (Book Value) | 94.30M |
| Book Value Per Share | 7.41 |
| Working Capital | 68.56M |
Cash Flow
In the last 12 months, operating cash flow was $27.14 million and capital expenditures -$12.93 million, giving a free cash flow of $14.21 million.
| Operating Cash Flow | 27.14M |
| Capital Expenditures | -12.93M |
| Free Cash Flow | 14.21M |
| FCF Per Share | $1.12 |
Margins
Gross margin is 76.96%, with operating and profit margins of 30.67% and 26.61%.
| Gross Margin | 76.96% |
| Operating Margin | 30.67% |
| Pretax Margin | 33.54% |
| Profit Margin | 26.61% |
| EBITDA Margin | 31.69% |
| EBIT Margin | 30.67% |
| FCF Margin | 18.30% |
Dividends & Yields
This stock pays an annual dividend of $0.68, which amounts to a dividend yield of 0.89%.
| Dividend Per Share | $0.68 |
| Dividend Yield | 0.89% |
| Dividend Growth (YoY) | -29.03% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 41.00% |
| Buyback Yield | -0.59% |
| Shareholder Yield | 0.29% |
| Earnings Yield | 2.11% |
| FCF Yield | 1.45% |
Analyst Forecast
The average price target for IRMD is $72.00, which is -6.26% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $72.00 |
| Price Target Difference | -6.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRMD has an Altman Z-Score of 35.88 and a Piotroski F-Score of 4.
| Altman Z-Score | 35.88 |
| Piotroski F-Score | 4 |